SCHEMBL6567640

SCHEMBL6567640

COc1ccc(NC(=O)NC(C)(C)C)cc1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.65
SMN1; SMN2 Q16637 5/20 0.59
NPC1 O15118 5/20 0.59
RAB9A P51151 5/20 0.59
MAPT P10636 5/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
KDM4E B2RXH2 1/20 0.59
GAA P10253 1/20 0.59
HPGD P15428 2/20 0.58
TP53 P04637 1/20 0.58
PKM P14618 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
IMPDH2 P12268 1/20 0.57
IMPDH1 P20839 1/20 0.57
ALDH1A1 P00352 7/20 0.57
GLA P06280 1/20 0.57
LMNA P02545 2/20 0.56
MAPK1 P28482 1/20 0.56
POLB P06746 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11250817 0.87 SMN1; SMN2 (0.55) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL6567544 0.85 POLB (0.56) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL6568629 0.84 IMPDH2 (0.58) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL11754054 0.83 SMN1; SMN2 (0.63) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL11685462 0.83 SMN1; SMN2 (0.63) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL31054226 0.81 SMN1; SMN2 (0.71) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL4342347 0.80 HTT (0.70) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL10777166 0.80 ALDH1A1 (0.68) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL1291893 0.80 SMN1; SMN2 (0.70) HTTSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL11789681 0.78 SMN1; SMN2 (0.67) HTTSMN1; SMN2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed